Disputatio:Oligodendroglioma anaplasticum

Pagina autotranslata

Versio hodierna haud utilis apparet: 1. Textui autotranslato errores maiores insunt, 2. Neuropathologia anno 2021 ab notione 'anaplastici' destitit. -> pagina nomine 'oligodendroglioma' (sine 'anaplasticum') necesse. Andreas Raether (disputatio) 11:33, 17 Decembris 2023 (UTC)

Oligodendroglioma anaplasticum

"== Revision to "anaplastic oligodendroglioma" ==

@Wname1 I want to explain why I've undone your changes to the article and moved it back to anaplastic oligodendroglioma (AOD).

- "Oligodendroglioma, IDH-mutant and 1p/19q-codeleted" has both a grade 2 and grade 3 subtype, which are the successors of "oligodendroglioma" and "AOD", respectively. This article doesn't contain anything about the grade 2 subtype.

- The article hasn't been updated to reflect the changes of the new terminology and molecular critera, greatly exemplified in these sentences: "About 50 to 70% of WHO grade III Oligodendrogliomas, IDH-mutant and 1p/19q-codeleted have combined allele losses on the short arm of chromosome 1 (1p) and the long arm of chromosome 19 (19q). This change is mostly referred to as "1p / 19q Co Deletion"." It also still uses Roman numerals for grades, mentions grade IV oligodendrogliomas, watchful waiting as a therapy etc.

As of now, the article doesn't cover "Oligodendroglioma, IDH-mutant and 1p/19q-codeleted" as defined by the 2021 WHO classification, but an obsolete entity. I've added an {{update}}-template to make readers aware. Cheers, User:MaligneRange 12:42, 18 December 2023 (UTC)" Wname1 (disputatio) 17:49, 19 Decembris 2023 (UTC)

Emendabisne textum autotranslatum mox? Andreas Raether (disputatio) 21:36, 21 Decembris 2023 (UTC)

Bona quaestio! Nisi quis paginam utilem esse censeat, nisi quis emendare velit, mox delebitur. Andrew Dalby (disputatio) 18:09, 22 Decembris 2023 (UTC)